Biostar Pharma (BSPM) Swings to Q2 Loss

Biostar Pharma (NASDAQ: BSPM) reported Q2 EPS of ($0.03), versus $0.11 reported last year. Revenue for the quarter came in at $14.2 million, versus $19.2 million reported last year.

For earnings history and earnings-related data on Biostar Pharma (BSPM) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79